Sangamo Therapeutics, Inc. (NASDAQ: SGMO) and TxCell S.A. announced today that they have entered into a definitive agreement on July ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE